BiotechTube
LEM Surgical

LEM Surgical

Zug, Switzerland· Est.
lemsurgical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $40M

Overview

LEM Surgical is a private, commercial-stage medical robotics company focused on transforming hard tissue surgery (orthopedics, spine, neurosurgery) through its innovative Dynamis robotic platform. The company, founded by a team of renowned surgeons and engineers from Bern, Switzerland, has successfully navigated regulatory pathways, securing FDA clearance in early 2025, positioning it for commercial launch. With a leadership and board boasting deep expertise from companies like Mazor Robotics (Medtronic) and Globus Medical, LEM Surgical is poised to enter a high-growth surgical robotics market with a differentiated, Swiss-engineered system. Its strategy leverages advanced robotics and key partnerships, such as with NVIDIA, to enhance surgical precision and outcomes.

OrthopedicsSpine SurgeryNeurosurgery

Technology Platform

Dynamis Robotic Surgical System: A next-generation, humanoid robotic platform integrated with advanced AI (partnering with NVIDIA) specifically designed for precision hard tissue (bone & joint) surgery. It aims to provide unparalleled dexterity and functionality for procedures in orthopedics, spine, and neurosurgery.

Funding History

2
Total raised:$40M
Series B$30M
Series A$10M

Opportunities

The global surgical robotics market, especially for orthopedics and spine, is large and growing, driven by demand for improved precision and outcomes.
LEM's humanoid design and AI integration offer a potential point of differentiation to capture market share from established players.
The Swiss-made quality and strong clinical advisory board provide credibility for adoption in top-tier hospitals.

Risk Factors

Intense competition from well-capitalized incumbents like Stryker and Medtronic poses a significant commercial challenge.
Successful market penetration requires building a robust sales organization and generating compelling long-term clinical data.
As a private company, scaling operations will be capital intensive, creating dependency on future fundraising.

Competitive Landscape

LEM Surgical competes in the crowded and well-established surgical robotics market for hard tissue procedures. Key competitors include Stryker (Mako) in joint replacement, Medtronic (Mazor/Stealth) and Globus Medical (ExcelsiusGPS) in spine, and Zimmer Biomet (Rosa). Differentiation is critical, and LEM is betting on its humanoid platform design and advanced AI partnership to offer superior versatility and functionality compared to current systems.

More companies in Switzerland →